Diet, genetic polymorphisms, detoxification, and health risks

Alternative Therapies in Health and Medicine

Volumn 13, Issue 2, 2007, Pages

  Lampe, Johanna W ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; GLUCURONIDE; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; ISOTHIOCYANIC ACID; MUTAGENIC AGENT; PLANT MEDICINAL PRODUCT; POLYCYCLIC AROMATIC HYDROCARBON; STEROID HORMONE; SULFATE; SULFORAPHANE; SULFOTRANSFERASE;

CANCER RISK; CONFERENCE PAPER; CRUCIFERA; DETOXIFICATION; DIET; ENVIRONMENTAL EXPOSURE; FOOD INTAKE; FOOD PROCESSING; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; GLUCURONIDATION; HEALTH HAZARD; HUMAN; MEAT; NUTRIENT SUPPLY; PROTEIN EXPRESSION; TASTE PREFERENCE;

BIOTRANSFORMATION; DIET; DIGESTIVE PHYSIOLOGY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE TRANSFERASE; HUMANS; INTESTINAL MUCOSA; NEOPLASMS; POLYMORPHISM, GENETIC;

EID: 33947246675     PISSN: 10786791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. Sinha R, Rothman N, Brown ED, et al. Pan-fried meat containing high levels of heterocyclic aromatic amines hut low levels of polycyclic aromatic hydrocarbons induces cytochrome P4501A2 activity in humans. Cancer Res. 1994;54(23):6154-6159.
2. MacLeod S, Sinha R, Kadlubar FF, Lang NP. Polymorphisms of CYP1AI and GSTMI influence the in vivo function of CYPIA2. Mutat Res. 1997;381(1-2):83-96.
3. Kiss I, Sandor J, Ember I. Allelic polymorphism of GSTM1 and NAT2 genes modifies dietary-induced DNA damage in colorectal mucosa. Eur J Cancer Prev. 2000;9(6):429-432.
4. Lampe JW, Peterson S. Brassica, biotransformation and cancer risk: genetic polymorphisms alter the preventive effects of cruciferous vegetables. J Nutr. 2002;13210):2991-2994.
5. Breinholt VM, Offord EA, Brouwer C, Nielsen SE, Brosen K, Friedberg T. In vitro investigation of cytochrome P450-mediated metabolism of dietary flavonoids. Food Chem Toxicol. 2002;40(5):609-616.
6. Walle T. Absorption and metabolism of flavonoids. Free Radic Biol Med. 2004;36(7):829-837.
7. Williamson G, Manach C. Bioavailability and bioefficacy of polyphenols in humans. H. Review of 93 intervention studies. Am J Clin Nutr. 2005;81(I Suppl):243S-255S.
8. Shephard SE, Zogg M, Burg G, Panizzon RG. Measurement of 5-methoxypsoralen and 8-methoxypsoralen in saliva of PUVA patients as a noninvasive, clinically relevant alternative to monitoring in blood. Arch Dermatol Res. 1999;291(9):491-499.
9. Erlund I, Meririnne E, Alfthan G, Aro A. Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. J Nutr. 2001;131(2):235-241.
10. Kuijsten A, Arts IC, Vree TB, Hollman PC. Pharmacokinetics of enterolignans in healthy men and women consuming a single dose of secoisolariciresinol diglucoside. J Nutr. 2005;135(4):795-801.
11. Sreerama L, Hedge MW, Sladek NE. Identification of a class 3 aldehyde dehydrogenase in human saliva and increased levels of this enzyme, glutathione S-transferases, and DT-diaphorase in the saliva of subjects who continually ingest large quantities of coffee or broccoli. Clin Cancer Res. 1995;1(10):1153-1163.
12. Seow A, Shi C-V, Chung F-L, et al. Urinary total isothiocyanate (ITC) in a population-based sample of middle-aged and older Chinese in Singapore: relationship with dietary total ITC and glutathione S-transferase M1/T1/P1 genotypes. Cancer Epidemiol Biomarkers Prev. 1998;7(9):775-781.
13. Seow A, Vainio H, Yu MC. Effect of glutathione-S-transferase polymorphisms on the cancer preventive potential of isothiocyanates: An epidemiological perspective. Mutat Res. 2005;592(1-2):58-67.
14. Lampe JW, Chen C, Li S, et al. Modulation of human glutathione S-transferases by botanically defined vegetable diets. Cancer Epidemiol Biomarkers Prev. 2000;9(8):787-793.
15. Gasper AV, Al-Janobi A, Smith JA, et al. Glutathione S-transferase M1 polymorphism and metabolism of sulforaphane from standard and high-glucosinolate broccoli. Am J Clin Nutr. 2005;82(6):1283-1291.
16. Wells PG, Mackenzie PI, Chowdhury JR, et al. Glucuronidation and the UDP-glucuronosyltransferases in health and disease. Drug Metab Dispos. 2004;32(3):281-290.
17. Miners JO, McKinnon RA, Mackenzie PI. Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance. Toxicology. 2002;181-182:453-456.
18. Williams JA, Hyland R, Jones BC, et al. Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios. Drug Metab Dispos. 2004;32(11):1201-1208.
19. Lampe JW, Bigler J, Horner N, Potter JD. UDP-glucuronosyltransferase (UGT1AI*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: Relationships to serum bilirubin concentrations. Pharmacogenetics. 1999;9(3):341-349.
20. Innocenti F, Undevia SD, Iyer L, et al. Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan. J Clin Oncol. 2004;22(8):1382-1388.
21. Bigler J, Whitton J, Lampe JW, Fosdick L, Bostick RM, Potter JD. CYP2C9 and UGT1A6 genotypes modulate the protective effect of NSAIDS on colon adenoma risk. Cancer Res. 2001;61(9):3566-3569.
22. Peters U, Sinha R, Bell DA, et al. Urinary mutagenesis and fried red meat intake: influence of cooking temperature, phenotype, and genotype of metabolizing enzymes in a controlled feeding study. Environ Mol Mutagen. 2004;43(1):53-74.
23. Peterson S, Bigler J, Horner NK, Potter JD, Lampe JW. Cruciferae interact with UGT1A1*28 polymorphism to determine serum bilirubin levels in humans. J Nutr. 2005;135(5):1051-1055.
24. Guillemette C, Millikan RC, Newman B, Housman DE. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans. Cancer Res. 2000;60(4):950-956.
25. Guillemette C, De Vivo I, Hankinson SE, et al. Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels. Cancer Epidemiol Biomarkers Prev. 2001;10(6):711-714.
26. Haiman CA, Hankinson SE, De Vivo I, et al. Polymorphisms in steroid hormone pathway genes and mammographic density. Breast Cancer Res Treat. 2003;77(1):27-36.
27. Sparks R, Ulrich CM, Bigler J, et al. UDP-glucuronosyltransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients. Breast Cancer Res. 2004;6(5):R488-R498.
28. Adegoke OJ, Shu XO, Gao YT, et al. Genetic polymorphisms in uridine diphosphoglucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer. Breast Cancer Res Treat. 2004;85(3):239-245.
29. MacLeod SL, Nowell S, Plaxco J, Lang NP. An allele-specific polymerase chain reaction method for the determination of the D85Y polymorphism in the human UDP-glucuronosyltransferase 2B15 gene in a case-control study of prostate cancer. Ann Surg Oncol. 2000;7(10):777-782.
30. Park J, Chen L, Shade K, et al. Asp85tyr polymorphism in the udp-glucuronosyltransferase (UGT) 2B15 gene and the risk of prostate cancer. J Urol. 2004;171(6 Pt 1):2484-2488.
31. Chanock S, Wacholder S. One gene and one outcome? No way. Trends Mol Med. 2002;8(6):266-269.
32. Nicas M, Lomax GP. A cost-benefit analysis of genetic screening for susceptibility to occupational toxicants. J Occup Environ Med. 1999;41(7):535-544.
33. Undevia SD, Gomez-Abuin G, Ratain MJ. Pharmacokinetic variability of anticancer agents. Nat Rev Cancer. 2005;5(6):447-458.